3 results  1 of 1 

1 Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
Fares Ayoub, Matthew Odenwald, Dejan Micic, Sushila R. Dalal, Joel Pekow, Russell D. Cohen, David T. Rubin, Atsushi Sakuraba
Intest Res.2022;20(2):240-250.   Published online 2022 February 8     DOI: http://dx.doi.org/10.5217/ir.2021.00091
      
2 Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
Cheng-Chun Ji, Shota Takano
Intest Res.2017;15(2):182-186.   Published online 2017 April 27     DOI: http://dx.doi.org/10.5217/ir.2017.15.2.182
      
3 Imaging of Anal Fistulas: Comparison of Computed Tomographic Fistulography and Magnetic Resonance Imaging
Changhu Liang, Yongchao Lu, Bin Zhao, Yinglin Du, Cuiyan Wang, Wanli Jiang
Korean J Radiol.2014;15(6):712-723.   Published online 2014 November 7     DOI: http://dx.doi.org/10.3348/kjr.2014.15.6.712
      

 1 of 1